Pharma channel feed

Lon­don court up­holds Mod­er­na patent in vac­cine dis­pute with Pfiz­er, but in­val­i­dates an­oth­er

11 months ago
Law

Up­dat­ed: Eli Lil­ly wins long-await­ed ap­proval for Alzheimer’s drug

11 months ago
FDA+

'Op­ti­miz­ing R&D struc­ture is al­so on the hori­zon, with­out ex­cep­tion,' new Sum­it­o­mo Phar­ma CEO says

11 months ago
Nikkei Biotechnology

Mod­er­na wins $176M BAR­DA award to fi­nance bird flu work

11 months ago
R&D

Check­point Ther­a­peu­tics re­files PD-L1 drug cosi­be­limab af­ter FDA re­jec­tion

11 months ago

FTC in­ves­ti­gates Te­va over patents, dou­bling down on 'bo­gus' Or­ange Book list­ings

11 months ago
Law

Seek­ing 'fi­nan­cial flex­i­bil­i­ty,' Es­pe­ri­on sells Eu­ro­pean roy­al­ty on cho­les­terol-low­er­ing drugs

11 months ago
Financing
Deals

Cas­sa­va says two se­nior em­ploy­ees in­clud­ed in fed­er­al probes

11 months ago
Law

Take­da to lay off more em­ploy­ees in Mass­a­chu­setts

11 months ago
People

FDA says can­cer drug cis­platin is no longer in short­age

11 months ago
FDA+
Manufacturing

Lil­ly inks ra­dio­phar­ma deal with Ra­dio­net­ics, with rights to buy the biotech

11 months ago
Deals

Aerovate plans to lay off near­ly all em­ploy­ees af­ter tri­al fail­ure

11 months ago
People
R&D

EMA's CHMP rec­om­mends 10 new drugs as Pierre Fab­re over­ac­tive blad­der med wins ap­proval

11 months ago
R&D

Mer­ck calls ACIP's pneu­mo­coc­cal rec­om­men­da­tion a 'missed op­por­tu­ni­ty,' ad­vo­cates for ex­pand­ing age group

11 months ago
FDA+

Fed­er­al grand ju­ry in­dicts Cas­sa­va col­lab­o­ra­tor for al­leged­ly de­fraud­ing NIH

11 months ago
Law

CMS spells out how states can join new cell and gene ther­a­py ac­cess pi­lot

11 months ago
FDA+

Why the Supreme Court's over­rule of Chevron has ma­jor im­pli­ca­tions for the FDA

11 months ago
FDA+
Law

In­side BAR­DA's multi­bil­lion-dol­lar ef­fort to fund long-shot biotechs for Covid

11 months ago
Coronavirus

Rovi teas­es ac­qui­si­tion of­fers for its CD­MO unit po­ten­tial­ly worth €2B to €3B

11 months ago
Deals
Manufacturing

Lykos takes an­oth­er hit as ICER lays out 'in­suf­fi­cien­t' ev­i­dence for MD­MA-based treat­ment

11 months ago
R&D

House pan­el ad­vances bill to al­low Medicare to cov­er obe­si­ty drugs

11 months ago
FDA+

What Co­herus' $40M sale of its Hu­mi­ra biosim­i­lar says about the crowd­ed mar­ket

11 months ago
Deals

Supreme Court nar­row­ly re­jects Pur­due bank­rupt­cy plan, says it gives Sack­lers too much pro­tec­tion

11 months ago
Law

Grail pi­o­neered mul­ti-can­cer tests. But the com­pa­ny’s rough pub­lic de­but shows the in­dus­try could be in trou­ble

11 months ago
Diagnostics
First page Previous page 48495051525354 Next page Last page
A service from the Financial Times